title: The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells.
abstract: When fighting cancer, knowledge on metabolism has always been important. Today, it matters more than ever. The restricted cataloging of cancer genomes is quite unlikely to achieve the task of curing cancer, unless it is integrated into metabolic networks that respond to and influence the constantly evolving cancer stem cell (CSC) cellular states. Once the genomic era of carcinogenesis had pushed the 1920s Otto Warburg's metabolic cancer hypothesis into obscurity for decades, the most recent studies begin to support a new developing paradigm, in which the molecular logic behind the conversion of non-CSCs into CSCs can be better understood in terms of the "metabolic facilitators" and "metabolic impediments" that operate as proximate openings and roadblocks, respectively, for the transcriptional events and signal transduction programs that ultimately orchestrate the intrinsic and/or microenvironmental paths to CSC cellular states. Here we propose that a profound understanding of how human carcinomas install a proper "Warburg effect version 2.0" allowing them to "run" the CSCs' "software" programs should guide a new era of metabolo-genomic-personalized cancer medicine. By viewing metabolic reprogramming of CSCs as an essential characteristic that allows dynamic, multidimensional and evolving cancer populations to compete successfully for their expansion on the organism, we now argue that CSCs bioenergetics might be another cancer hallmark. A definitive understanding of metabolic reprogramming in CSCs may complement or to some extent replace, the 30-y-old paradigm of targeting oncogenes to treat human carcinomas, because it can be possible to metabolically create non-permissive or "hostile" metabotypes to prevent the occurrence of CSC cellular states with tumor- and metastasis-initiating capacity.
authors.affiliation: Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain. jmenendez@iconcologia.net
authors.forename: Javier A
authors.initials: JA
authors.lastname: Menendez
authors.forename: Jorge
authors.initials: J
authors.lastname: Joven
authors.forename: Sílvia
authors.initials: S
authors.lastname: Cufí
authors.forename: Bruna
authors.initials: B
authors.lastname: Corominas-Faja
authors.forename: Cristina
authors.initials: C
authors.lastname: Oliveras-Ferraros
authors.forename: Elisabet
authors.initials: E
authors.lastname: Cuyàs
authors.forename: Begoña
authors.initials: B
authors.lastname: Martin-Castillo
authors.forename: Eugeni
authors.initials: E
authors.lastname: López-Bonet
authors.forename: Tomás
authors.initials: T
authors.lastname: Alarcón
authors.forename: Alejandro
authors.initials: A
authors.lastname: Vazquez-Martin
mesh_terms: D019069:Cell Respiration / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D055808:Drug Discovery / Q000639:trends*; D004734:Energy Metabolism / Q000502:physiology*; D006019:Glycolysis; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D053858:Metabolic Networks and Pathways / Q000502:physiology*; D008954:Models, Biological; D014411:Neoplastic Stem Cells / Q000378:metabolism*
keywords: Warburg effect; cancer stem cells; metabolism; pluripotency; reprogramming; stemness
references.citation: Cancer Prev Res (Phila). 2010 Nov;3(11):1361-4
references.pmid: 20959519
references.citation: Nat Rev Cancer. 2010 Aug;10(8):526-7
references.pmid: 21137109
references.citation: Nat Rev Cancer. 2007 Oct;7(10):763-77
references.pmid: 17882277
references.citation: Aging (Albany NY). 2012 Jun;4(6):393-401
references.pmid: 22713507
references.citation: Cell Cycle. 2010 Sep 15;9(18):3807-14
references.pmid: 20890129
references.citation: Curr Mol Med. 2010 Oct;10(7):674-91
references.pmid: 20712585
references.citation: J Cardiovasc Transl Res. 2013 Feb;6(1):10-21
references.pmid: 23247633
references.citation: Cell Metab. 2013 Jan 8;17(1):113-24
references.pmid: 23274086
references.citation: Cold Spring Harb Symp Quant Biol. 2011;76:155-64
references.pmid: 22071265
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14470-5
references.pmid: 22908280
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Stem Cells. 2009 May;27(5):1050-6
references.pmid: 19415771
references.citation: Nature. 2009 Aug 27;460(7259):1149-53
references.pmid: 19668189
references.citation: J Clin Oncol. 2010 Dec 10;28(35):5219-28
references.pmid: 20975063
references.citation: Cell Stem Cell. 2011 Dec 2;9(6):588-98
references.pmid: 22136932
references.citation: Cell Metab. 2011 Aug 3;14(2):264-71
references.pmid: 21803296
references.citation: Nature. 2010 Apr 15;464(7291):972-4
references.pmid: 20393534
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Cell Stem Cell. 2009 Apr 3;4(4):336-47
references.pmid: 19341623
references.citation: Nat Biotechnol. 2009 Mar;27(3):281-7
references.pmid: 19252483
references.citation: Cancer Res. 2013 Mar 1;73(5):1524-35
references.pmid: 23288510
references.citation: Nat Rev Drug Discov. 2013 Jan;12(1):35-50
references.pmid: 23274470
references.citation: Semin Cell Dev Biol. 2012 Jun;23(4):362-9
references.pmid: 22349059
references.citation: Breast Cancer Res. 2005;7(3):86-95
references.pmid: 15987436
references.citation: Cell. 2009 Nov 13;139(4):693-706
references.pmid: 19878981
references.citation: Aging Cell. 2012 Feb;11(1):41-50
references.pmid: 21981310
references.citation: Adv Cancer Res. 2008;100:133-58
references.pmid: 18620095
references.citation: Nat Rev Cancer. 2004 Nov;4(11):891-9
references.pmid: 15516961
references.citation: Nat Rev Cancer. 2011 Apr;11(4):268-77
references.pmid: 21390058
references.citation: J Natl Cancer Inst. 2008 May 7;100(9):672-9
references.pmid: 18445819
references.citation: Cell Cycle. 2012 Mar 1;11(5):974-89
references.pmid: 22333578
references.citation: Breast Cancer Res Treat. 2011 Nov;130(2):387-98
references.pmid: 21188630
references.citation: Science. 2002 Apr 26;296(5568):698-700
references.pmid: 11976444
references.citation: Carcinogenesis. 2010 Apr;31(4):567-76
references.pmid: 20080835
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Nature. 2009 Aug 27;460(7259):1140-4
references.pmid: 19668186
references.citation: Cell Metab. 2008 Jan;7(1):11-20
references.pmid: 18177721
references.citation: Science. 2011 Mar 25;331(6024):1553-8
references.pmid: 21436442
references.citation: Breast Cancer Res Treat. 2011 Apr;126(2):355-64
references.pmid: 20458531
references.citation: Clin Cancer Res. 2012 Feb 1;18(3):612-8
references.pmid: 22298893
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1397-402
references.pmid: 21220315
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: Cell Res. 2009 Nov;19(11):1227-8
references.pmid: 19881523
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: Clin Exp Metastasis. 2012 Oct;29(7):653-5
references.pmid: 22678423
references.citation: Nature. 2009 Aug 27;460(7259):1145-8
references.pmid: 19668190
references.citation: Drug Resist Updat. 2011 Aug-Oct;14(4-5):212-23
references.pmid: 21600837
references.citation: Biomark Med. 2011 Dec;5(6):715-29
references.pmid: 22103608
references.citation: Cold Spring Harb Symp Quant Biol. 2011;76:23-9
references.pmid: 22429931
references.citation: Science. 2009 May 22;324(5930):1029-33
references.pmid: 19460998
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
references.pmid: 19666588
references.citation: PLoS One. 2011;6(6):e20914
references.pmid: 21698063
references.citation: Trends Mol Med. 2012 Sep;18(9):509-15
references.pmid: 22795735
references.citation: Nat Med. 2011 Mar;17(3):297-303
references.pmid: 21383744
references.citation: Curr Mol Med. 2013 Mar;13(3):459-63
references.pmid: 23331018
references.citation: Cell Res. 2011 Mar;21(3):486-501
references.pmid: 21321600
references.citation: Genes Dev. 2009 Sep 15;23(18):2134-9
references.pmid: 19696146
references.citation: Cell Cycle. 2012 Oct 1;11(19):3521-2
references.pmid: 22935702
references.citation: J Pathol. 2011 Jan;223(2):147-61
references.pmid: 21125672
references.citation: J Biol Chem. 2010 Aug 13;285(33):25308-13
references.pmid: 20538613
references.citation: Genes Dev. 2011 Sep 15;25(18):1895-908
references.pmid: 21937710
references.citation: J Bioenerg Biomembr. 2007 Jun;39(3):259-65
references.pmid: 17712532
references.citation: Stem Cells Dev. 2013 Jan 1;22(1):37-50
references.pmid: 22998387
references.citation: Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5
references.pmid: 21498687
references.citation: Am J Clin Nutr. 2011 Apr;93(4):891S-6
references.pmid: 21325438
references.citation: Nature. 2009 Apr 9;458(7239):719-24
references.pmid: 19360079
references.citation: Nat Biotechnol. 2012 Jul 10;30(7):679-92
references.pmid: 22781697
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2813-20
references.pmid: 18539959
references.citation: Nat Rev Cancer. 2010 Jan;10(1):51-7
references.pmid: 20029423
references.citation: J Cell Sci. 2010 Jul 15;123(Pt 14):2357-68
references.pmid: 20592182
references.citation: Cell. 2007 Jul 27;130(2):223-33
references.pmid: 17662938
references.citation: Cell Cycle. 2010 Nov 15;9(22):4461-8
references.pmid: 21088486
references.citation: Cancer Cell. 2012 Mar 20;21(3):283-96
references.pmid: 22439924
references.citation: Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6
references.pmid: 16488983
references.citation: Antioxid Redox Signal. 2013 Jul 20;19(3):285-98
references.pmid: 22901241
references.citation: Cell Cycle. 2013 Jan 15;12(2):207-18
references.pmid: 23287468
references.citation: Cell Stem Cell. 2011 Aug 5;9(2):103-11
references.pmid: 21816362
references.citation: Biochim Biophys Acta. 2011 Jun;1807(6):543-51
references.pmid: 21035425
references.citation: Nature. 2009 Aug 27;460(7259):1136-9
references.pmid: 19668188
references.citation: J Clin Oncol. 2010 Sep 1;28(25):4006-12
references.pmid: 20498387
references.citation: Cell Cycle. 2011 Apr 1;10(7):1144-51
references.pmid: 21368581
references.citation: Cell. 2011 Aug 19;146(4):633-44
references.pmid: 21854987
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Cell Cycle. 2012 Aug 15;11(16):2963-4
references.pmid: 22871729
references.citation: Cancer Res. 2006 May 15;66(10):5216-23
references.pmid: 16707446
references.citation: Int J Dev Biol. 2010;54(11-12):1729-41
references.pmid: 21305470
references.citation: Cancer Cell. 2008 Jun;13(6):472-82
references.pmid: 18538731
references.citation: Semin Cancer Biol. 2010 Apr;20(2):98-106
references.pmid: 20188173
references.citation: Sci Rep. 2012;2:964
references.pmid: 23236586
references.citation: Semin Cancer Biol. 2010 Apr;20(2):93-7
references.pmid: 20188174
references.citation: Cell. 2010 Nov 12;143(4):508-25
references.pmid: 21074044
references.citation: J Cardiovasc Transl Res. 2010 Feb;3(1):13-23
references.pmid: 20221419
references.citation: Stem Cells. 2011 Sep;29(9):1338-48
references.pmid: 21732474
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Genes Dev. 2009 Mar 1;23(5):537-48
references.pmid: 19270154
references.citation: Oncogene. 2013 Oct 17;32(42):5111-22
references.pmid: 23208501
references.citation: Ann N Y Acad Sci. 2012 Apr;1254:82-9
references.pmid: 22548573
references.citation: Cell Cycle. 2011 Nov 1;10(21):3658-77
references.pmid: 22052357
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925
references.citation: Cell Res. 2012 Jan;22(1):168-77
references.pmid: 22064701
references.citation: Stem Cells. 2010 Apr;28(4):721-33
references.pmid: 20201066
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683